RTW INVESTMENTS, LP
Q1 2020 13F-HR Holdings
Net value change ($000)
-306,709
(-11.7%)
New positions
9
Sold out positions
3
Turnover %
8.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Global Blood Therapeutics, Inc. | 36,759 | NEW |
| OYST | 33,932 | NEW |
| TNDM | 28,554 | NEW |
| NTRA | 24,231 | 178.5% |
| BELLUS Health Inc. | 18,166 | 49.7% |
| WAVE LIFE SCIENCES LTD | 18,095 | 132.4% |
| KRRO | 15,126 | 69.5% |
| TXG | 11,467 | 3009.7% |
| STAA | 11,167 | 105.1% |
| AVDL | 10,572 | 41.2% |
Top Reduces (Value $000, Stocks/ETFs)
| RCKT | -148,118 | -38.7% |
| MIST | -55,432 | -87.5% |
| AXSM | -44,185 | -41.6% |
| ACHILLION PHARMACEUTICALS INC | -44,076 | -100.0% |
| SRPT | -26,396 | -33.8% |
| ESTA | -22,705 | -40.4% |
| QTTB | -21,665 | -24.1% |
| PRQR | -21,124 | -44.6% |
| STOK | -19,210 | -19.1% |
| MyoKardia, Inc. | -18,857 | -34.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|